Galactus is a modern hybrid-indica cultivar derived from the parent strain Joe's Lemonade. This strain has been developed for cultivators seeking a balance between a moderate difficulty level and a high yield, and it is suitable for both indoor and outdoor growing environments. Growers can expect a 60-day flowering period for this THC-dominant plant. Its genetic contribution to the industry continues through its notable offspring, Galactus F2.

The terpene profile of Galactus is characterized by a complex hierarchy beginning with myrcene as the primary constituent, followed by limonene, caryophyllene, linalool, humulene, and beta-pinene. The profile rounds out with trace amounts of bisabolol, guaiol, pinene, ocimene, camphene, and terpinolene. This specific arrangement of terpenes defines the sensory experience, providing a nuanced aromatic and flavor profile that relies on the interplay between these chemical components.

As a THC-dominant variety, Galactus is primarily utilized for its therapeutic potential in addressing pain, stress, and sleep difficulties. Users consistently report effects of being relaxed, calm, and focused upon consumption. Due to these specific properties, it serves as a functional tool for those managing physical discomfort or daily tension, reinforcing its position within modern breeding programs that prioritize targeted medicinal applications and stable, high-yielding development.